NCT07161518
Characterizing Transcranial Focused Ultrasound Neuromodulation During Sedation
Enrolling by Invitation
PHASE4Ages 18–65InterventionalBasic scienceStanford UniversityInvestigator-initiated
~10 participants
Updated 2026-03-10 on ClinicalTrials.gov
What's tested:Low-intensity transcranial ultrasoundPropofol
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Electroencephalographic power spectral density
Measured over 3 hour period concurrent with delivery of propofol anesthesia
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Electroencephalographic power spectral density3 hour period concurrent with delivery of propofol anesthesia
Electroencephalographic (EEG) power will be computed using the multitaper spectrogram method applied to frontal, central, and posterior EEG leads and will be reported in the 0.5 Hz (delta) to 40 Hz (gamma) range inclusive of all bands therein (delta, theta, alpha, beta, gamma).